🇮🇹 Marstacimab in Italy

Marstacimab (marstacimab) regulatory status in Italy.

Marketing authorisation

AIFA

  • Local brand name: Hympavzi
  • Status: approved

Marstacimab in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Rare Disease approved in Italy

Frequently asked questions

Is Marstacimab approved in Italy?

Yes. AIFA has authorised it.

Who is the marketing authorisation holder for Marstacimab in Italy?

Pfizer Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.